- Home
- TMQ vs ZLAB Comparison
TMQ vs ZLAB Comparison
Compare TMQ & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMQ
- ZLAB
- Stock Information
- Founded
- TMQ 2004
- ZLAB 2013
- Country
- TMQ Canada
- ZLAB China
- Employees
- TMQ N/A
- ZLAB N/A
- Industry
- TMQ Precious Metals
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- TMQ Basic Materials
- ZLAB Health Care
- Exchange
- TMQ Nasdaq
- ZLAB Nasdaq
- Market Cap
- TMQ 226.7M
- ZLAB 3.6B
- IPO Year
- TMQ N/A
- ZLAB 2017
- Fundamental
- Price
- TMQ $1.89
- ZLAB $35.19
- Analyst Decision
- TMQ
- ZLAB Buy
- Analyst Count
- TMQ 0
- ZLAB 5
- Target Price
- TMQ N/A
- ZLAB $54.28
- AVG Volume (30 Days)
- TMQ 613.8K
- ZLAB 689.4K
- Earning Date
- TMQ 07-10-2025
- ZLAB 08-07-2025
- Dividend Yield
- TMQ N/A
- ZLAB N/A
- EPS Growth
- TMQ N/A
- ZLAB N/A
- EPS
- TMQ N/A
- ZLAB N/A
- Revenue
- TMQ N/A
- ZLAB $418,326,000.00
- Revenue This Year
- TMQ N/A
- ZLAB $44.07
- Revenue Next Year
- TMQ N/A
- ZLAB $49.13
- P/E Ratio
- TMQ N/A
- ZLAB N/A
- Revenue Growth
- TMQ N/A
- ZLAB 43.72
- 52 Week Low
- TMQ $0.47
- ZLAB $16.01
- 52 Week High
- TMQ $2.09
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- TMQ 71.19
- ZLAB 49.90
- Support Level
- TMQ $1.30
- ZLAB $32.31
- Resistance Level
- TMQ $2.02
- ZLAB $35.72
- Average True Range (ATR)
- TMQ 0.12
- ZLAB 1.10
- MACD
- TMQ 0.05
- ZLAB -0.34
- Stochastic Oscillator
- TMQ 65.97
- ZLAB 60.17
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.